PCaI patient education conference: March 2, Ft. Myers, FL

Prostate Cancer International (PCaI) is excited to be holding its next patient education / information conference in Fort Myers, FL, on March 2, 2019, from 9:00 a.m. to 5:00 p.m. For complete details of the meeting agenda, the speakers, how to register, and other facts, please click here. … READ MORE …

PCF publishes updated patient handbook

The Prostate Cancer Foundation (PCF) has just published the 2019 update to its Prostate Cancer Patient Guide, which is a very useful (and free) introduction to prostate cancer for patients and their caregivers. … READ MORE …

Patient education / information meeting in Fort Myers, FL, in March

Prostate Cancer International (PCaI) will be holding its next patient education / information meeting in Fort Myers, FL, on March 2, 2019 from 9:00 a.m. to 5:00 p.m. For complete details of the meeting agenda, the speakers, how to register, and other facts, please click here. … READ MORE …

“Prostate Cancer Today” — Dr. Frans Debruyne joins meeting faculty

This will be our last reminder that Prostate Cancer International is holding its second annual prostate cancer patient meeting (“Prostate Cancer Today: Living Well; Choosing Wisely”) on October 13, 2018, in Virginia Beach, near Norfolk, Virginia, USA. As of this morning we have > 170 advance registrants for this meeting. … READ MORE …

“Prostate Cancer Today” — patient education meeting in Virginia Beach

This is another reminder that Prostate Cancer International will be holding its second annual prostate cancer patient meeting (“Prostate Cancer Today: Living Well; Choosing Wisely”) on October 13, 2018, in Virginia Beach, near Norfolk, Virginia, USA. … READ MORE …

The importance of listening to patients

A report yesterday on on the MedPage Today web site quotes Scott Gottlieb, MD, the Commissioner of the U.S. Food & Drug Administration (FDA) on the importance of “Listening to patients” and on how patients’ perspectives can inform drug development, drug review, and physicians’ prescribing habits. … READ MORE …

Prostate ablation using HIFU — the role of patient preference information

A newly published review by staff of the Center for Devices and Radiological Health (CDRH at the U.S. Food & Drug Administration (FD) addresses the potential role for patient preference information (PPI) in determining patient perceptions of the “value” of high-intensity focused ultrasound (HIFU) and similar techniques in the management of prostate cancer. … READ MORE …